Big effect
A six-month trial in 76 colorectal cancer patients found Lactobacillus supplementation significantly improved multiple markers of oxidative stress — but the benefit was seen in a very specific clinical population, not the general public.
This is an early, well-designed study suggesting that gut bacteria may help manage oxidative damage after cancer surgery, but because it's among the first of its kind and limited to post-surgery CRC patients, the results can't yet be generalized to healthy people or other conditions.
Oxidative stress — an imbalance between free radicals and the body's antioxidant defenses — is linked to tissue damage and disease progression. In this randomized controlled trial, colorectal cancer patients who took a Lactobacillus supplement for six months showed improvements in several blood markers of oxidative stress, including higher antioxidant enzymes and lower damage markers. These findings are promising but come from a single study in a specific patient group, so more research is needed before drawing broader conclusions.
Where this fits in the evidence
This is among the first studies we've indexed on Lactobacillus amylovorus for Reduced Oxidative Stress — treat it as an early signal until more research accumulates.
The study
- Randomized Controlled Trial (RCT)
- n = 76
- 2025-11-24
- Journal of medical biochemistry
- PubMed: 41281285
- DOI: 10.5937/jomb0-56528
- Full study breakdown →
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.